UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (46), p.19997-20002

2010

Volltextzugriff (PDF)

The role of dysfunctional HDL in atherosclerosis

Journal of lipid research, 2009-04, Vol.50 (Suppl), p.S145-S149

2009

Volltextzugriff (PDF)

A novel approach to oral apoA-I mimetic therapy[S]

Journal of lipid research, 2013-04, Vol.54 (4), p.995-1010

2013

Volltextzugriff (PDF)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

Journal of lipid research, 2008-11, Vol.49 (11), p.2302-2311

2008

Volltextzugriff (PDF)

Mechanisms of Disease: proatherogenic HDL-an evolving field

Nature clinical practice. Endocrinology & metabolism, 2006-09, Vol.2 (9), p.504-511

2006

Volltextzugriff (PDF)

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]

Journal of lipid research, 2013-12, Vol.54 (12), p.3403-3418

2013

Volltextzugriff (PDF)

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

Drug metabolism letters, 2010-08, Vol.4 (3), p.139-148

2010

Volltextzugriff (PDF)

High-density lipoprotein loses its anti-inflammatory properties during acute Influenza A infection

Circulation (New York, N.Y.), 2001-05, Vol.103 (18), p.2283-2288

2001

Volltextzugriff (PDF)

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

Nature reviews cardiology, 2011-04, Vol.8 (4), p.222-232

2011

Volltextzugriff (PDF)

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

Arteriosclerosis, thrombosis, and vascular biology, 2001-04, Vol.21 (4), p.481-488

2001

Volltextzugriff (PDF)

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

Journal of lipid research, 2007-11, Vol.48 (11), p.2344-2353

2007

Volltextzugriff (PDF)

LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice[S]

Journal of lipid research, 2012-06, Vol.53 (6), p.1126-1133

2012

Volltextzugriff (PDF)

Understanding changes in high density lipoproteins during the acute phase response

Arteriosclerosis, thrombosis, and vascular biology, 2006-08, Vol.26 (8), p.1687-1688

2006

Volltextzugriff (PDF)

An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice

Arteriosclerosis, thrombosis, and vascular biology, 2005-09, Vol.25 (9), p.1932-1937

2005

Volltextzugriff (PDF)

Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension

Pulmonary circulation, 2015-12, Vol.5 (4), p.640-648

2015

Volltextzugriff (PDF)

High-density lipoprotein: antioxidant and anti-inflammatory properties

Current atherosclerosis reports, 2007-09, Vol.9 (3), p.244-248

2007

Volltextzugriff (PDF)

Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal

Current opinion in lipidology, 2004-12, Vol.15 (6), p.645-649

2004

Volltextzugriff (PDF)

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

Journal of lipid research, 2004-06, Vol.45 (6), p.993-1007

2004

Volltextzugriff (PDF)

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature

Arteriosclerosis, thrombosis, and vascular biology, 2012-11, Vol.32 (11), p.2553-2560

2012

Volltextzugriff (PDF)

Structure and function of HDL mimetics

Arteriosclerosis, thrombosis, and vascular biology, 2010-02, Vol.30 (2), p.164-168

2010

Volltextzugriff (PDF)

HDL as a biomarker, potential therapeutic target, and therapy

Diabetes (New York, N.Y.), 2009-12, Vol.58 (12), p.2711-2717

2009

Volltextzugriff (PDF)

Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts

Antioxidants & redox signaling, 2015-06, Vol.22 (18), p.1633-1645

2015

Volltextzugriff (PDF)

Potential clinical utility of high-density lipoprotein-mimetic peptides

Current opinion in lipidology, 2006-08, Vol.17 (4), p.440-444

2006

Volltextzugriff (PDF)

D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes

Circulation (New York, N.Y.), 2004-11, Vol.110 (20), p.3252-3258

2004

Volltextzugriff (PDF)

Apolipoprotein A-I mimetic peptides

Current atherosclerosis reports, 2009, Vol.11 (1), p.52-57

2009

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(55)
Buchkapitel
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

The role of dysfunctional HDL in atherosclerosis

A novel approach to oral apoA-I mimetic therapy[S]

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I

Mechanisms of Disease: proatherogenic HDL-an evolving field

Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

High-density lipoprotein loses its anti-inflammatory properties during acute Influenza A infection

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice[S]

Understanding changes in high density lipoproteins during the acute phase response

An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice

Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension

High-density lipoprotein: antioxidant and anti-inflammatory properties

Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature

Structure and function of HDL mimetics

HDL as a biomarker, potential therapeutic target, and therapy

Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts

Potential clinical utility of high-density lipoprotein-mimetic peptides

D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes

Apolipoprotein A-I mimetic peptides

Suchergebnisse filtern